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The first French National Rare Disease Plan allowed the
establishment of 131 centres of expertise (CEs) from 2004
to 2007. The process of evaluation elaborated with the
HAS (Haute Autorité de Santé) was based on a cycle of
5 years: three years after the certification, the CEs were
asked for a document of auto-evaluation and at 5 years
there was a visit on site to complete the evaluation. As the
certification of CEs was done over a period of 4 years, all
the CEs were not evaluated at the same time and it
resulted in a complex scheme with heterogeneity of the
evaluation according to the time point of the process.
The items collected during autoevaluation consisted in
general information regarding the composition of the
team and of the steering committee, the methods used for
the elaboration of the document and quantitative data
concerning the activities (clinics, hospitalizations, geogra-
phical origin of the patients, proportion of children). Six
specific missions of the CEs were also evaluated: expertise,
referral, research, epidemiology, healthcare pathway and
medicosocial organization. The documented ended with
an action plan on which the experts relied for their evalua-
tion during the visit on site at 5 years. This process
demonstrated many positive aspects: constructive stimula-
tion of the actors, commitment of institution direction
and set up of a virtuous circle based on the fundamental
three steps: anticipation, implementation and evaluation.
However this process had many caveats: redundancy of
some items that led to confusion in the responses, lack of
support for the methodology mandatory to evaluate the
impact of the CEs actions, heaviness of the organisation of
the visit on site and most of all impossibility to retrieve
essential information and to analyse them as the docu-
ments were elaborated on a word file with free text. The
evaluation of the first plan by the high council of public
health thus concluded it was necessary to simplify and to
optimize the efficiency of the process. In addition, it has to
take into account the new ambitions of the 2nd plan.
A working group dedicated to this question collaborated
with the HAS and elaborated a simplified document for
certification. The process now includes an on-line simpli-
fied annual activity report based on quantitative and semi-
quantitative data. These reports will be analysed each year
by a permanent group – with adjustment of the financial
support- together with a final report at 4 years based on
the new certification document. Visit on site will be
decided only if problems appear during this follow-up or
on request of the centre.
Published: 11 November 2014
doi:10.1186/1750-1172-9-S1-O4
Cite this article as: Sarnacki: Evaluation of Centres: the French
experience since 2009. Orphanet Journal of Rare Diseases 2014
9(Suppl 1):O4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitExpert centre on ARM Hopital Necker Enfants Malades, APHP, Paris Descartes
University, France
Sarnacki Orphanet Journal of Rare Diseases 2014, 9(Suppl 1):O4
http://www.ojrd.com/content/9/S1/O4
© 2014 Sarnacki; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
